ImmunologyEMBO Molecular MedicinePeer-reviewed
Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase and ERK/AKT/NF-κB signaling
Adeline Cezard, Déborah Bréa, Virginie Vasseur…·Mustapha Si‐Tahar
This study identifies cis-aconitate as a dual-action antiviral and anti-inflammatory agent that reduces influenza mortality in mice by targeting viral polymerase and ERK/AKT/NF-κB signaling.
5 citationstop 1%